Bicyclic substituted hexahydrobenz[e]isoindole alpha-1-...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/06 (2006.01) A61K 31/505 (2006.01) C07D 401/06 (2006.01) C07D 471/04 (2006.01) C07D 473/04 (2006.01) C07D 475/02 (2006.01) C07D 487/04 (2006.01) C07D 491/04 (2006.01) C07D 495/04 (2006.01) C07D 498/04 (2006.01)

Patent

CA 2210966

The present invention relates to a compound of formula (I) and the pharmaceutically acceptable salts thereof wherein W is a bicyclic heterocyclic ring system. The compounds are .alpha.-1 adrenergic antagonists and are useful in the treatment of BPH; also disclosed are .alpha.-1 antagonist compositions and a method for antagonizing .alpha.-1 receptors and treating BPH.

La présente invention concerne un composé de formule (I) ainsi que ses sels pharmaceutiquement acceptables, W étant un noyau hétérocyclique bicyclique. Les composés sont des antagonistes .alpha.-1 adrénergiques et ils sont utiles dans le traitement de l'hyperplasie prostatique bénigne. L'invention concerne aussi des compositions antagonistes .alpha.-1 adrénergiques et un procédé servant à rendre antagonistes des récepteurs .alpha.-1 et à traiter l'hyperplasie prostatique bénigne.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bicyclic substituted hexahydrobenz[e]isoindole alpha-1-... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclic substituted hexahydrobenz[e]isoindole alpha-1-..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic substituted hexahydrobenz[e]isoindole alpha-1-... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2028797

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.